Physician profile
Robert Kelsey
NPI 1053314740
$512.20
in general payments reported to CMS, 2019-2025
18 companies · $39.61 in 2025
The $39.61 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.59 · 2021: $18.26 · 2022: $155 · 2023: $60.60 · 2024: $210 · 2025: $39.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $119.51 | 2022-2024 | Motoband, Va-Lcp |
| Stryker Corporation | $97.44 | 2024 | Augment Injectable, Ortholoc 2 Lapifuse |
| Organogenesis INC. | $47.08 | 2022-2023 | Puraply |
| Horizon Therapeutics Plc | $29.44 | 2020-2021 | |
| Convatec INC. | $24.92 | 2024 | |
| Nevro Corp. | $19.25 | 2024 | Senza |
| Smith+Nephew, INC. | $19.25 | 2025 | Bone Anchors With Arthroscopic Delivery System |
| Axogen | $18.41 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.05 | 2024 | Exparel |
| Bioventus LLC | $16.22 | 2023 | Exogen Ultrasound Bone Healing System |
| Medline Industries LP | $15.60 | 2022 | |
| Averitas Pharma INC. | $15.49 | 2023 | Qutenza |
| Biotissue Holdings INC. | $14.44 | 2024 | |
| Paratek Pharmaceuticals, INC. | $13.94 | 2025 | Nuzyra |
| Integra Lifesciences Corporation | $13.77 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $13.53 | 2024 | Arista Ah Flexitip |
| Heron Therapeutics, INC. | $9.44 | 2022 | |
| Kerecis Limited | $6.42 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kelsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.